Skip Navigation LinksHome > About the Journal

About the Journal

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

Publication & Editorial Staff Contacts

Phil Daly

Production Editor
Kavi Ganeshananthan

Rany Aing

Translation, Rights & Licensing
Silvia Serra

LWW Business Offices
Citi Building, 41st Floor
25 Canada Square
Canary Wharf
London E14 5LQ, UK
Phone: +44(0)20 3197 6500

International Advertising Representative
Avia Potashnik
Advertising & Sponsorship Manager, Europe
Phone: +44 203 197 6722

Professor Stuart A Montgomery
International Clinical Psychopharmacology
P.O. Box 8751
London W13 8WH